CN101747322A - Pyridazinone derivatives with 1,2,4-triazole schiff base, preparation method and application thereof - Google Patents
Pyridazinone derivatives with 1,2,4-triazole schiff base, preparation method and application thereof Download PDFInfo
- Publication number
- CN101747322A CN101747322A CN 201010041815 CN201010041815A CN101747322A CN 101747322 A CN101747322 A CN 101747322A CN 201010041815 CN201010041815 CN 201010041815 CN 201010041815 A CN201010041815 A CN 201010041815A CN 101747322 A CN101747322 A CN 101747322A
- Authority
- CN
- China
- Prior art keywords
- triazole
- phenyl
- compound
- trimethoxyphenyl
- pyridazine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 1,2,4-triazole schiff base Chemical class 0.000 title claims abstract description 31
- AAILEWXSEQLMNI-UHFFFAOYSA-N 1h-pyridazin-6-one Chemical class OC1=CC=CN=N1 AAILEWXSEQLMNI-UHFFFAOYSA-N 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 239000002262 Schiff base Substances 0.000 title abstract description 7
- 150000001875 compounds Chemical class 0.000 claims abstract description 110
- 238000006243 chemical reaction Methods 0.000 claims abstract description 36
- 239000002994 raw material Substances 0.000 claims abstract description 18
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 claims abstract description 12
- HKOOXMFOFWEVGF-UHFFFAOYSA-N phenylhydrazine Chemical class NNC1=CC=CC=C1 HKOOXMFOFWEVGF-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229940067157 phenylhydrazine Drugs 0.000 claims abstract description 7
- LUMLZKVIXLWTCI-NSCUHMNNSA-N (e)-2,3-dichloro-4-oxobut-2-enoic acid Chemical compound OC(=O)C(\Cl)=C(/Cl)C=O LUMLZKVIXLWTCI-NSCUHMNNSA-N 0.000 claims abstract description 6
- 229940074391 gallic acid Drugs 0.000 claims abstract description 6
- 235000004515 gallic acid Nutrition 0.000 claims abstract description 6
- ZAKLKBFCSHJIRI-UHFFFAOYSA-N mucochloric acid Natural products OC1OC(=O)C(Cl)=C1Cl ZAKLKBFCSHJIRI-UHFFFAOYSA-N 0.000 claims abstract description 6
- 150000003935 benzaldehydes Chemical class 0.000 claims abstract description 5
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzenecarboxaldehyde Natural products O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 claims abstract description 4
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 claims abstract description 4
- SJSOFNCYXJUNBT-UHFFFAOYSA-N 3,4,5-trimethoxybenzoic acid Chemical compound COC1=CC(C(O)=O)=CC(OC)=C1OC SJSOFNCYXJUNBT-UHFFFAOYSA-N 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- SNTWKPAKVQFCCF-UHFFFAOYSA-N 2,3-dihydro-1h-triazole Chemical compound N1NC=CN1 SNTWKPAKVQFCCF-UHFFFAOYSA-N 0.000 claims description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 19
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 18
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 15
- 238000001953 recrystallisation Methods 0.000 claims description 14
- 239000007787 solid Substances 0.000 claims description 14
- 239000003814 drug Substances 0.000 claims description 13
- IWPZKOJSYQZABD-UHFFFAOYSA-N 3,4,5-trimethoxybenzoic acid Natural products COC1=CC(OC)=CC(C(O)=O)=C1 IWPZKOJSYQZABD-UHFFFAOYSA-N 0.000 claims description 12
- 238000010992 reflux Methods 0.000 claims description 12
- WUGMUGFWKHXWPK-UHFFFAOYSA-N 4-chloro-2-phenylpyridazin-3-one Chemical class O=C1C(Cl)=CC=NN1C1=CC=CC=C1 WUGMUGFWKHXWPK-UHFFFAOYSA-N 0.000 claims description 11
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 claims description 10
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical compound C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 claims description 9
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- 238000000967 suction filtration Methods 0.000 claims description 9
- 239000013078 crystal Substances 0.000 claims description 8
- 229910052731 fluorine Inorganic materials 0.000 claims description 8
- 239000011737 fluorine Substances 0.000 claims description 8
- 239000000047 product Substances 0.000 claims description 8
- 238000003786 synthesis reaction Methods 0.000 claims description 8
- 230000015572 biosynthetic process Effects 0.000 claims description 7
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- 229910052801 chlorine Inorganic materials 0.000 claims description 6
- 239000000460 chlorine Substances 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 125000005843 halogen group Chemical group 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000005457 ice water Substances 0.000 claims description 6
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 claims description 6
- 125000005323 thioketone group Chemical group 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- 230000002507 anti-phytoviral effect Effects 0.000 claims description 4
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- HZNQSWJZTWOTKM-UHFFFAOYSA-N 2,3,4-trimethoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C(OC)=C1OC HZNQSWJZTWOTKM-UHFFFAOYSA-N 0.000 claims description 3
- 229960000583 acetic acid Drugs 0.000 claims description 3
- 238000003916 acid precipitation Methods 0.000 claims description 3
- 150000001299 aldehydes Chemical class 0.000 claims description 3
- 239000012043 crude product Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 125000001153 fluoro group Chemical group F* 0.000 claims description 3
- 230000004927 fusion Effects 0.000 claims description 3
- 239000012362 glacial acetic acid Substances 0.000 claims description 3
- 230000006698 induction Effects 0.000 claims description 3
- 238000007603 infrared drying Methods 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 3
- 235000015320 potassium carbonate Nutrition 0.000 claims description 3
- 238000000746 purification Methods 0.000 claims description 3
- 239000000376 reactant Substances 0.000 claims description 3
- 239000011541 reaction mixture Substances 0.000 claims description 3
- 238000010898 silica gel chromatography Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 238000009156 water cure Methods 0.000 claims description 3
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 2
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims description 2
- VKWCOHVAHQOJGU-UHFFFAOYSA-N 4,5-dichloro-2-phenylpyridazin-3-one Chemical compound O=C1C(Cl)=C(Cl)C=NN1C1=CC=CC=C1 VKWCOHVAHQOJGU-UHFFFAOYSA-N 0.000 claims description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052794 bromium Inorganic materials 0.000 claims description 2
- 230000008859 change Effects 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 claims description 2
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 150000002431 hydrogen Chemical class 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 239000011630 iodine Substances 0.000 claims description 2
- 229910052740 iodine Inorganic materials 0.000 claims description 2
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 claims description 2
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 claims description 2
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 230000036961 partial effect Effects 0.000 claims description 2
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 45
- 230000000694 effects Effects 0.000 abstract description 33
- 230000002401 inhibitory effect Effects 0.000 abstract description 15
- 241000724252 Cucumber mosaic virus Species 0.000 abstract description 13
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical group C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 abstract description 12
- 150000003852 triazoles Chemical group 0.000 abstract description 9
- 241000700605 Viruses Species 0.000 abstract description 7
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 238000006798 ring closing metathesis reaction Methods 0.000 abstract 2
- 238000006266 etherification reaction Methods 0.000 abstract 1
- 238000006177 thiolation reaction Methods 0.000 abstract 1
- 239000002585 base Substances 0.000 description 32
- 230000004071 biological effect Effects 0.000 description 15
- 238000012360 testing method Methods 0.000 description 14
- 230000003385 bacteriostatic effect Effects 0.000 description 12
- 230000035484 reaction time Effects 0.000 description 12
- 238000009333 weeding Methods 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 11
- 241000723873 Tobacco mosaic virus Species 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 230000002194 synthesizing effect Effects 0.000 description 9
- 238000011160 research Methods 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 7
- 230000005764 inhibitory process Effects 0.000 description 7
- 241000257159 Musca domestica Species 0.000 description 6
- 241000209140 Triticum Species 0.000 description 6
- 235000021307 Triticum Nutrition 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 239000000575 pesticide Substances 0.000 description 6
- 241000238631 Hexapoda Species 0.000 description 5
- 240000007594 Oryza sativa Species 0.000 description 5
- 235000007164 Oryza sativa Nutrition 0.000 description 5
- 230000000749 insecticidal effect Effects 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 235000009566 rice Nutrition 0.000 description 5
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 4
- 239000003630 growth substance Substances 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- HZVOZRGWRWCICA-UHFFFAOYSA-N methanediyl Chemical compound [CH2] HZVOZRGWRWCICA-UHFFFAOYSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- AMNAZJFEONUVTD-KEWDHRJRSA-N (2s,3s,4s,5r,6r)-6-(4-amino-2-oxopyrimidin-1-yl)-4,5-dihydroxy-3-[[(2s)-3-hydroxy-2-[[2-(methylamino)acetyl]amino]propanoyl]amino]oxane-2-carboxamide Chemical compound O1[C@H](C(N)=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC)[C@H](O)[C@@H](O)[C@@H]1N1C(=O)N=C(N)C=C1 AMNAZJFEONUVTD-KEWDHRJRSA-N 0.000 description 3
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 3
- 241000123650 Botrytis cinerea Species 0.000 description 3
- 241000222122 Candida albicans Species 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- FEACDOXQOYCHKU-UHFFFAOYSA-N Gougerotin Natural products CNCC(=O)NC1=NC(=O)N(C=C1)C2OC(C(O)C(NC(=O)C(N)CO)C2O)C(=O)N FEACDOXQOYCHKU-UHFFFAOYSA-N 0.000 description 3
- 241000819999 Nymphes Species 0.000 description 3
- 206010039509 Scab Diseases 0.000 description 3
- 241000221696 Sclerotinia sclerotiorum Species 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 239000005864 Sulphur Substances 0.000 description 3
- 241000607479 Yersinia pestis Species 0.000 description 3
- 239000003905 agrochemical Substances 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 230000000840 anti-viral effect Effects 0.000 description 3
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 3
- 238000009833 condensation Methods 0.000 description 3
- 230000005494 condensation Effects 0.000 description 3
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 238000005286 illumination Methods 0.000 description 3
- 230000000452 restraining effect Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- FPYUJUBAXZAQNL-UHFFFAOYSA-N 2-chlorobenzaldehyde Chemical compound ClC1=CC=CC=C1C=O FPYUJUBAXZAQNL-UHFFFAOYSA-N 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 240000002754 Chenopodium giganteum Species 0.000 description 2
- 235000008091 Chenopodium giganteum Nutrition 0.000 description 2
- 241000221204 Cryptococcus neoformans Species 0.000 description 2
- 240000008067 Cucumis sativus Species 0.000 description 2
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- 244000058871 Echinochloa crus-galli Species 0.000 description 2
- 241000150562 Hantaan orthohantavirus Species 0.000 description 2
- 101001087394 Homo sapiens Tyrosine-protein phosphatase non-receptor type 1 Proteins 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- XRHGWAGWAHHFLF-UHFFFAOYSA-N Isazofos Chemical compound CCOP(=S)(OCC)OC=1N=C(Cl)N(C(C)C)N=1 XRHGWAGWAHHFLF-UHFFFAOYSA-N 0.000 description 2
- 241001330975 Magnaporthe oryzae Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 2
- KDISMIMTGUMORD-UHFFFAOYSA-N N-acetylpiperidine Natural products CC(=O)N1CCCCC1 KDISMIMTGUMORD-UHFFFAOYSA-N 0.000 description 2
- 244000172412 Physalis pruinosa Species 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 2
- 102100033001 Tyrosine-protein phosphatase non-receptor type 1 Human genes 0.000 description 2
- ORFPWVRKFLOQHK-UHFFFAOYSA-N amicarbazone Chemical compound CC(C)C1=NN(C(=O)NC(C)(C)C)C(=O)N1N ORFPWVRKFLOQHK-UHFFFAOYSA-N 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- XOEMATDHVZOBSG-UHFFFAOYSA-N azafenidin Chemical compound C1=C(OCC#C)C(Cl)=CC(Cl)=C1N1C(=O)N2CCCCC2=N1 XOEMATDHVZOBSG-UHFFFAOYSA-N 0.000 description 2
- 150000003851 azoles Chemical class 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000004166 bioassay Methods 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- 229960003405 ciprofloxacin Drugs 0.000 description 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 2
- AGKSTYPVMZODRV-UHFFFAOYSA-N imibenconazole Chemical compound C1=CC(Cl)=CC=C1CSC(CN1N=CN=C1)=NC1=CC=C(Cl)C=C1Cl AGKSTYPVMZODRV-UHFFFAOYSA-N 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 239000010977 jade Substances 0.000 description 2
- 229960002509 miconazole Drugs 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 229940049547 paraxin Drugs 0.000 description 2
- SATCULPHIDQDRE-UHFFFAOYSA-N piperonal Chemical compound O=CC1=CC=C2OCOC2=C1 SATCULPHIDQDRE-UHFFFAOYSA-N 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- 150000004892 pyridazines Chemical group 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- FFSJPOPLSWBGQY-UHFFFAOYSA-N triazol-4-one Chemical compound O=C1C=NN=N1 FFSJPOPLSWBGQY-UHFFFAOYSA-N 0.000 description 2
- AMFGTOFWMRQMEM-UHFFFAOYSA-N triazophos Chemical compound N1=C(OP(=S)(OCC)OCC)N=CN1C1=CC=CC=C1 AMFGTOFWMRQMEM-UHFFFAOYSA-N 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 1
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- OYWRDHBGMCXGFY-UHFFFAOYSA-N 1,2,3-triazinane Chemical compound C1CNNNC1 OYWRDHBGMCXGFY-UHFFFAOYSA-N 0.000 description 1
- 150000000178 1,2,4-triazoles Chemical class 0.000 description 1
- MBIZXFATKUQOOA-UHFFFAOYSA-N 1,3,4-thiadiazole Chemical compound C1=NN=CS1 MBIZXFATKUQOOA-UHFFFAOYSA-N 0.000 description 1
- RAIPHJJURHTUIC-UHFFFAOYSA-N 1,3-thiazol-2-amine Chemical compound NC1=NC=CS1 RAIPHJJURHTUIC-UHFFFAOYSA-N 0.000 description 1
- WURBVZBTWMNKQT-UHFFFAOYSA-N 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-one Chemical compound C1=NC=NN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 WURBVZBTWMNKQT-UHFFFAOYSA-N 0.000 description 1
- PWMWNFMRSKOCEY-UHFFFAOYSA-N 1-Phenyl-1,2-ethanediol Chemical compound OCC(O)C1=CC=CC=C1 PWMWNFMRSKOCEY-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- HZJKXKUJVSEEFU-UHFFFAOYSA-N 2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile Chemical compound C=1C=C(Cl)C=CC=1C(CCCC)(C#N)CN1C=NC=N1 HZJKXKUJVSEEFU-UHFFFAOYSA-N 0.000 description 1
- ZXTHWIZHGLNEPG-UHFFFAOYSA-N 2-phenyl-4,5-dihydro-1,3-oxazole Chemical compound O1CCN=C1C1=CC=CC=C1 ZXTHWIZHGLNEPG-UHFFFAOYSA-N 0.000 description 1
- ZPSJGADGUYYRKE-UHFFFAOYSA-N 2H-pyran-2-one Chemical compound O=C1C=CC=CO1 ZPSJGADGUYYRKE-UHFFFAOYSA-N 0.000 description 1
- GUSWJGOYDXFJSI-UHFFFAOYSA-N 3,6-dichloropyridazine Chemical compound ClC1=CC=C(Cl)N=N1 GUSWJGOYDXFJSI-UHFFFAOYSA-N 0.000 description 1
- RVECZHFENFMRHJ-UHFFFAOYSA-N 3,6-difluoropyridazine Chemical compound FC1=CC=C(F)N=N1 RVECZHFENFMRHJ-UHFFFAOYSA-N 0.000 description 1
- PIKNVEVCWAAOMJ-UHFFFAOYSA-N 3-fluorobenzaldehyde Chemical compound FC1=CC=CC(C=O)=C1 PIKNVEVCWAAOMJ-UHFFFAOYSA-N 0.000 description 1
- AVPYQKSLYISFPO-UHFFFAOYSA-N 4-chlorobenzaldehyde Chemical compound ClC1=CC=C(C=O)C=C1 AVPYQKSLYISFPO-UHFFFAOYSA-N 0.000 description 1
- RREANTFLPGEWEN-MBLPBCRHSA-N 7-[4-[[(3z)-3-[4-amino-5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidin-2-yl]imino-5-fluoro-2-oxoindol-1-yl]methyl]piperazin-1-yl]-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(\N=C/3C4=CC(F)=CC=C4N(CN4CCN(CC4)C=4C(=CC=5C(=O)C(C(O)=O)=CN(C=5C=4)C4CC4)F)C\3=O)=NC=2)N)=C1 RREANTFLPGEWEN-MBLPBCRHSA-N 0.000 description 1
- 241000150489 Andes orthohantavirus Species 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241001124076 Aphididae Species 0.000 description 1
- 241001425390 Aphis fabae Species 0.000 description 1
- 241000228197 Aspergillus flavus Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- JMTJHFAMPAPFHE-UHFFFAOYSA-N C(C)(=O)N.N=1NC(C=CC1)=O Chemical class C(C)(=O)N.N=1NC(C=CC1)=O JMTJHFAMPAPFHE-UHFFFAOYSA-N 0.000 description 1
- QAZRMNRWRMTORL-UHFFFAOYSA-N C1=CC=NN=C1.O=C1C=CN=N1 Chemical class C1=CC=NN=C1.O=C1C=CN=N1 QAZRMNRWRMTORL-UHFFFAOYSA-N 0.000 description 1
- 244000197813 Camelina sativa Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241001157813 Cercospora Species 0.000 description 1
- 241000530549 Cercospora beticola Species 0.000 description 1
- 240000001817 Cereus hexagonus Species 0.000 description 1
- JYURCKLIXDIDDF-UHFFFAOYSA-N Cl.NC=1SC=CN1.N=1NC(C=CC1)=O Chemical class Cl.NC=1SC=CN1.N=1NC(C=CC1)=O JYURCKLIXDIDDF-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 201000007336 Cryptococcosis Diseases 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000223195 Fusarium graminearum Species 0.000 description 1
- 241000223221 Fusarium oxysporum Species 0.000 description 1
- 241000526118 Fusarium solani f. radicicola Species 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 241000254023 Locusta Species 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- 241000191938 Micrococcus luteus Species 0.000 description 1
- 244000128833 Mimulus luteus Species 0.000 description 1
- 239000005811 Myclobutanil Substances 0.000 description 1
- 241000409991 Mythimna separata Species 0.000 description 1
- RPLXELUFYRWECQ-UHFFFAOYSA-N N=1NC(C=CC1)=O.C(C1=CC=CC=C1)(=O)NC(=O)N Chemical class N=1NC(C=CC1)=O.C(C1=CC=CC=C1)(=O)NC(=O)N RPLXELUFYRWECQ-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000358422 Nephotettix cincticeps Species 0.000 description 1
- 241000150452 Orthohantavirus Species 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 241000488583 Panonychus ulmi Species 0.000 description 1
- 241000736122 Parastagonospora nodorum Species 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 241000233805 Phoenix Species 0.000 description 1
- 241000233616 Phytophthora capsici Species 0.000 description 1
- 206010050661 Platelet aggregation inhibition Diseases 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000233639 Pythium Species 0.000 description 1
- 241001361634 Rhizoctonia Species 0.000 description 1
- 241000813090 Rhizoctonia solani Species 0.000 description 1
- 240000005384 Rhizopus oryzae Species 0.000 description 1
- 150000004753 Schiff bases Chemical group 0.000 description 1
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241000344246 Tetranychus cinnabarinus Species 0.000 description 1
- 241001454293 Tetranychus urticae Species 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- LJTFFORYSFGNCT-UHFFFAOYSA-N Thiocarbohydrazide Chemical compound NNC(=S)NN LJTFFORYSFGNCT-UHFFFAOYSA-N 0.000 description 1
- 235000001667 Vitex agnus castus Nutrition 0.000 description 1
- 244000063464 Vitex agnus-castus Species 0.000 description 1
- 241000222126 [Candida] glabrata Species 0.000 description 1
- 150000003869 acetamides Chemical class 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 229950003476 aminothiazole Drugs 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000001857 anti-mycotic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000949 anxiolytic effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 150000008047 benzoylureas Chemical class 0.000 description 1
- 125000000051 benzyloxy group Chemical class [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 208000032343 candida glabrata infection Diseases 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 1
- SKOLWUPSYHWYAM-UHFFFAOYSA-N carbonodithioic O,S-acid Chemical compound SC(S)=O SKOLWUPSYHWYAM-UHFFFAOYSA-N 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 239000012954 diazonium Substances 0.000 description 1
- FBOUIAKEJMZPQG-BLXFFLACSA-N diniconazole-M Chemical compound C1=NC=NN1/C([C@H](O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1Cl FBOUIAKEJMZPQG-BLXFFLACSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- HJUFTIJOISQSKQ-UHFFFAOYSA-N fenoxycarb Chemical compound C1=CC(OCCNC(=O)OCC)=CC=C1OC1=CC=CC=C1 HJUFTIJOISQSKQ-UHFFFAOYSA-N 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 229940042795 hydrazides for tuberculosis treatment Drugs 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- BRWIZMBXBAOCCF-UHFFFAOYSA-N hydrazinecarbothioamide Chemical compound NNC(N)=S BRWIZMBXBAOCCF-UHFFFAOYSA-N 0.000 description 1
- 238000006698 hydrazinolysis reaction Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 229960004125 ketoconazole Drugs 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 150000002611 lead compounds Chemical group 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000029052 metamorphosis Effects 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 230000000361 pesticidal effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- LIGACIXOYTUXAW-UHFFFAOYSA-N phenacyl bromide Chemical class BrCC(=O)C1=CC=CC=C1 LIGACIXOYTUXAW-UHFFFAOYSA-N 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 150000003053 piperidines Chemical class 0.000 description 1
- 239000005648 plant growth regulator Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 150000003217 pyrazoles Chemical class 0.000 description 1
- SRXDBMFVRUGWNJ-UHFFFAOYSA-N pyrazolo[5,1-c][1,2,4]triazine Chemical compound N1=NC=CN2N=CC=C21 SRXDBMFVRUGWNJ-UHFFFAOYSA-N 0.000 description 1
- QXOXHGUPISQLPW-UHFFFAOYSA-N pyridazine-4-carbonitrile Chemical compound N#CC1=CC=NN=C1 QXOXHGUPISQLPW-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- HBMJWWWQQXIZIP-UHFFFAOYSA-N silicon carbide Chemical compound [Si+]#[C-] HBMJWWWQQXIZIP-UHFFFAOYSA-N 0.000 description 1
- 229910010271 silicon carbide Inorganic materials 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000005732 thioetherification reaction Methods 0.000 description 1
- WHLUQAYNVOGZST-UHFFFAOYSA-N tifenamil Chemical group C=1C=CC=CC=1C(C(=O)SCCN(CC)CC)C1=CC=CC=C1 WHLUQAYNVOGZST-UHFFFAOYSA-N 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- QKIWQBLNTSQOLY-UHFFFAOYSA-N tpa-023 Chemical compound CCN1N=CN=C1COC(C(=C1)C(C)(C)C)=NN2C1=NN=C2C1=CC=CC=C1F QKIWQBLNTSQOLY-UHFFFAOYSA-N 0.000 description 1
- NKNFWVNSBIXGLL-UHFFFAOYSA-N triazamate Chemical compound CCOC(=O)CSC1=NC(C(C)(C)C)=NN1C(=O)N(C)C NKNFWVNSBIXGLL-UHFFFAOYSA-N 0.000 description 1
- DZCJZBPBJLJJCT-UHFFFAOYSA-N triazolo[4,5-e]thiadiazine Chemical class N1=NSC2=NN=NC2=C1 DZCJZBPBJLJJCT-UHFFFAOYSA-N 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010041815 CN101747322B (en) | 2010-01-20 | 2010-01-20 | Pyridazinone derivatives with 1,2,4-triazole schiff base, preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010041815 CN101747322B (en) | 2010-01-20 | 2010-01-20 | Pyridazinone derivatives with 1,2,4-triazole schiff base, preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101747322A true CN101747322A (en) | 2010-06-23 |
CN101747322B CN101747322B (en) | 2013-06-19 |
Family
ID=42474999
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201010041815 Expired - Fee Related CN101747322B (en) | 2010-01-20 | 2010-01-20 | Pyridazinone derivatives with 1,2,4-triazole schiff base, preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101747322B (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103193723A (en) * | 2013-04-01 | 2013-07-10 | 西南石油大学 | Benzotriazole Schiff base compound and preparation method thereof |
CN103613553A (en) * | 2013-12-09 | 2014-03-05 | 兴义民族师范学院 | S-triazole Schiff base bisamide derivative as well as preparation method and usage thereof |
CN104086494A (en) * | 2014-07-23 | 2014-10-08 | 张远强 | Compounds with terminally-disubstituted methyl triazole Schiff base structures as well as preparation methods and applications of compounds |
CN104086495A (en) * | 2014-07-23 | 2014-10-08 | 张远强 | Compounds with terminally-disubstituted triazole Schiff base structure as well as preparation methods and applications of compounds |
CN104086496A (en) * | 2014-07-23 | 2014-10-08 | 张远强 | Antithrombotic compounds as well as preparation methods and applications of antithrombotic compounds |
CN104098520A (en) * | 2014-07-23 | 2014-10-15 | 张远强 | Phenyl triazole schiff base compound as well as preparation method and application thereof |
CN105924432A (en) * | 2016-07-13 | 2016-09-07 | 青岛农业大学 | Pyridazinone derivative, and preparation method and application thereof |
CN107216322A (en) * | 2017-07-28 | 2017-09-29 | 漳州卫生职业学院 | The synthetic method of triazole Liu isoxazoles |
CN108409664A (en) * | 2018-02-14 | 2018-08-17 | 江苏医药职业学院 | A kind of organic synthesis of schiff base compounds and the method that crystal is prepared by the substance |
CN112552241A (en) * | 2019-09-10 | 2021-03-26 | 中石化南京化工研究院有限公司 | Synthesis method of pyridazinone |
CN113735842A (en) * | 2020-05-27 | 2021-12-03 | 河北农业大学 | 1,2, 4-triazole Schiff base thioether derivatives, and preparation method and application thereof |
CN116969955A (en) * | 2023-09-25 | 2023-10-31 | 中国药科大学 | [1,2,4] triazole [4,3-b ] pyridazine compound and preparation method and application thereof |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104140398B (en) * | 2014-07-23 | 2015-11-04 | 张远强 | Compound, the Preparation Method And The Use of methyl-triazole schiff bases class formation |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100453541C (en) * | 2005-09-08 | 2009-01-21 | 沈阳化工研究院 | Substituted oxdiazole or triazole thioketone compounds, preparation and application thereof |
-
2010
- 2010-01-20 CN CN 201010041815 patent/CN101747322B/en not_active Expired - Fee Related
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103193723B (en) * | 2013-04-01 | 2015-06-03 | 西南石油大学 | Benzotriazole Schiff base compound and preparation method thereof |
CN103193723A (en) * | 2013-04-01 | 2013-07-10 | 西南石油大学 | Benzotriazole Schiff base compound and preparation method thereof |
CN103613553A (en) * | 2013-12-09 | 2014-03-05 | 兴义民族师范学院 | S-triazole Schiff base bisamide derivative as well as preparation method and usage thereof |
CN104086496B (en) * | 2014-07-23 | 2015-09-30 | 张远强 | A kind of antithrombotic compound, Preparation Method And The Use |
CN104086496A (en) * | 2014-07-23 | 2014-10-08 | 张远强 | Antithrombotic compounds as well as preparation methods and applications of antithrombotic compounds |
CN104098520A (en) * | 2014-07-23 | 2014-10-15 | 张远强 | Phenyl triazole schiff base compound as well as preparation method and application thereof |
CN104086495A (en) * | 2014-07-23 | 2014-10-08 | 张远强 | Compounds with terminally-disubstituted triazole Schiff base structure as well as preparation methods and applications of compounds |
CN104086495B (en) * | 2014-07-23 | 2015-09-09 | 张远强 | End disubstituted triazole schiff bases structural compounds, Preparation Method And The Use |
CN104086494A (en) * | 2014-07-23 | 2014-10-08 | 张远强 | Compounds with terminally-disubstituted methyl triazole Schiff base structures as well as preparation methods and applications of compounds |
CN104098520B (en) * | 2014-07-23 | 2016-01-20 | 张远强 | Phenyltriazole schiff base compounds, Preparation Method And The Use |
CN105924432A (en) * | 2016-07-13 | 2016-09-07 | 青岛农业大学 | Pyridazinone derivative, and preparation method and application thereof |
CN107216322A (en) * | 2017-07-28 | 2017-09-29 | 漳州卫生职业学院 | The synthetic method of triazole Liu isoxazoles |
CN108409664A (en) * | 2018-02-14 | 2018-08-17 | 江苏医药职业学院 | A kind of organic synthesis of schiff base compounds and the method that crystal is prepared by the substance |
CN112552241A (en) * | 2019-09-10 | 2021-03-26 | 中石化南京化工研究院有限公司 | Synthesis method of pyridazinone |
CN112552241B (en) * | 2019-09-10 | 2022-07-08 | 中石化南京化工研究院有限公司 | Synthesis method of pyridazinone |
CN113735842A (en) * | 2020-05-27 | 2021-12-03 | 河北农业大学 | 1,2, 4-triazole Schiff base thioether derivatives, and preparation method and application thereof |
CN113735842B (en) * | 2020-05-27 | 2023-01-31 | 河北农业大学 | 1,2, 4-triazole Schiff base thioether derivatives, and preparation method and application thereof |
CN116969955A (en) * | 2023-09-25 | 2023-10-31 | 中国药科大学 | [1,2,4] triazole [4,3-b ] pyridazine compound and preparation method and application thereof |
CN116969955B (en) * | 2023-09-25 | 2023-12-19 | 中国药科大学 | [1,2,4] triazole [4,3-b ] pyridazine compound and preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN101747322B (en) | 2013-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101747322B (en) | Pyridazinone derivatives with 1,2,4-triazole schiff base, preparation method and application thereof | |
WO2012130798A1 (en) | Herbicidally and fungicidally active 3-phneylisoxazoline-5-carboxamides and 3-phneylisoxazoline-5-thioamides | |
BRPI0714887A2 (en) | pyridazine derivatives | |
JPS61501032A (en) | Herbicide 2↓-aryl↓-1,2,4↓-triazine↓-3,5(2H,4H)↓-dione compounds and their sulfur analogs | |
BRPI0806894A2 (en) | Pyridazine derivatives, processes for their preparation and their use as fungicides | |
TW200906807A (en) | Piperazine compounds having herbicidal action | |
JP6397820B2 (en) | 3-Heteroaryl-isoxazoline-5-carboxamides and 3-heteroaryl-isoxazoline-5-thioamides exhibiting herbicidal and bactericidal activity | |
BRPI0718180A2 (en) | Pyridazine derivatives | |
CN103613553A (en) | S-triazole Schiff base bisamide derivative as well as preparation method and usage thereof | |
CN112608307A (en) | Heterocyclic ring substituted 1,3, 4-oxadiazole hydrazide compounds, and preparation method and application thereof | |
TW201204249A (en) | Use of dithiine derivatives in crop protection and the protection of materials | |
CN109942567B (en) | 1,3,4-oxa (thia) diazolyl imidazole compound and preparation method and application thereof | |
JP2011506515A (en) | Novel pyridazine derivatives for the treatment of cancer useful as fungicides | |
CN108059629B (en) | Pyrimidine-containing substituted pyrazole compound and preparation method and application thereof | |
TW201022213A (en) | Heterocyclically substituted anilinopyrimidines | |
CN111285814B (en) | Quinazolinone compound containing hydrazone structural unit or stereoisomer thereof, or salt or solvate thereof | |
TW200932238A (en) | Novel pyridazine derivatives | |
TW201026690A (en) | Thienylaminopyrimidines as fungicides | |
CN113278020A (en) | Pityriacitrin alkaloid derivative containing acylthiourea structure and preparation method and application thereof | |
JP5940452B2 (en) | Aminopropenoic acid compounds as fungicides | |
CN110776548A (en) | Acetoxy ursolic acid piperazine compounds containing isopropanolamine substructure as well as preparation method and application thereof | |
CN109232534B (en) | Heterocyclic diarylamine-containing pyrazole formamide compound and preparation method and application thereof | |
CN113620894A (en) | Oxadiazole thioether compounds containing amide substructure as well as preparation method and application thereof | |
JPH06172321A (en) | Substituted aminopyrimidine derivative, its production and pest exterminating agent comprising the same as active ingredient | |
CN111454202A (en) | Heteroaryl formanilide compound containing pentafluorothio and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Xue Wei Inventor after: Zheng Guoyu Inventor after: Wei Xue Inventor after: Li Haichang Inventor after: Gong Huayu Inventor before: Xue Wei Inventor before: Zheng Guoyu Inventor before: Wei Xue |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: XUE WEI ZHENG GUOYU WEI XUE TO: XUE WEI ZHENG GUOYU WEI XUE LI HAICHANG GONG HUAYU |
|
CI01 | Publication of corrected invention patent application |
Correction item: Inventor Correct: Xue Wei|Zheng Yuguo|Wei Xue|Li Haichang|Gong Huayu False: Xue Wei|Zheng Guoyu|Wei Xue|Li Haichang|Gong Huayu Number: 32 Volume: 28 |
|
ERR | Gazette correction |
Free format text: CORRECT: INVENTOR; FROM: XUE WEI; ZHENG GUOYU, WEI XUE, LI HAICHANG, GONG HUAYU TO: XUE WEI; ZHENG YUGUO, WEI XUE, LI HAICHANG, GONG HUAYU |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191031 Address after: 538101 Jiangping Zhenjiang Ping Industrial Park, Dongxing City, Fangchenggang City, Guangxi Zhuang Autonomous Region Patentee after: GUANGXI DONGXING DINGKANG PLASTIC INDUSTRY Co.,Ltd. Address before: 550025 Huaxi District, Guizhou District, Guizhou University, North District of, science and technology division, North Campus of Guizhou University Patentee before: Guizhou University |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130619 Termination date: 20220120 |